FDA Adverse Event Injury Summary report: N

WAVEWRITER ALPHA PRIME 16

MDR report key: 21226240 · Received January 23, 2025

Report

Report Number
3006630150-2025-00181
Event Type
Injury
Date Received
January 23, 2025
Date of Event
October 15, 2024
Report Date
April 8, 2025
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
LGW
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NO
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: BRAND NAME: INFINION CX. UPN: M365SC2317700. MODEL: SC-2317-70. SERIAL: (B)(6). BATCH: 5072154.

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: BRAND NAME: INFINION CX. UPN: M365SC2317700. MODEL: SC-2317-70. SERIAL: (B)(6). BATCH: 5072154. UNIQUE IDENTIFIER (UDI) # (B)(4). THE RETURNED IPG WAS ANALYZED AND FOUND TO BE IN THE EOS STATE. HOWEVER, THE ANALYSIS OF THE DATA LOG INDICATED THAT THE IPG REACHED ITS EOS 1 YEAR, 4 MONTHS, AND 2 DAYS AFTER THE INITIAL PROGRAMMING. THE AVERAGE ENERGY USE INDEX (EUI) RECORDED WAS 39.1, ALIGNING WITH AN ESTIMATED THEORETICAL BATTERY LIFESPAN OF 9 MONTHS AND 21 DAYS. THIS INDICATES THAT THE BATTERY'S LIFESPAN FELL WITHIN THE PROJECTED RANGE. ADDITIONALLY, THE IPG DISPLAYED TYPICAL FEATURES DURING THE VISUAL AND FUNCTIONAL INSPECTION. VISUAL AND X-RAY INSPECTION OF THE RETURNED LEAD REVEALED THAT THIS LEAD WAS BENT/KINKED NEAR THE SET SCREW MARK OF THE CLIK ANCHOR AND MULTIPLE CABLES WERE COMPLETELY BROKEN AT THIS LOCATION. THERE ARE NO EXPOSED CABLES AT THE FRACTURE LOCATION. LABORATORY ANALYSIS DETERMINED THAT THE CAUSE OF THE BROKEN CABLES IS DUE TO MECHANICAL STRESS FROM POSSIBLE FLEXING OF THE LEAD AT THE EXIT POINT OF THE CLIK ANCHOR.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT RECEIVED THE ELECTIVE REPLACEMENT INDICTOR (ERI) AND END OF LIFE (EOL) MESSAGES FOR THEIR NON-RECHARGEABLE IMPLANTABLE PULSE GENERATOR (IPG). IT WAS INITIALLY STATED THAT PATIENT EXPERIENCED INADEQUATE STIMULATION AND A RETURN OF THEIR PRE-EXISTING PAIN. IT WAS LATER THEN STATED BY THE PAIN NURSE THAT IT WAS VERY HARD TO GET A CLEAR ANSWER FROM THE PATIENT ON WHETHER THEY HAD ANY STIMULATION ISSUES. THE NON-RECHARGEABLE IPG HAD TO BE REPLACED. PRE-OPERATIVELY, IT WAS NOTED THAT THE LEAD DISPLAYED HIGH IMPEDANCES ON MULTIPLE CONTACTS. THEREFORE, THE PHYSICIAN DECIDED TO EXPLANT AND REPLACE BOTH THE IPG AND LEAD. POST OPERATIVELY, THE PATIENT WAS NOTED TO HAVE RECOVERED AND RECEIVING PAIN RELIEF.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT RECEIVED THE ELECTIVE REPLACEMENT INDICTOR (ERI) AND END OF LIFE (EOL) MESSAGES FOR THEIR NON-RECHARGEABLE IMPLANTABLE PULSE GENERATOR (IPG). IT WAS INITIALLY STATED THAT PATIENT EXPERIENCED INADEQUATE STIMULATION AND A RETURN OF THEIR PRE-EXISTING PAIN. IT WAS LATER THEN STATED BY THE PAIN NURSE THAT IT WAS VERY HARD TO GET A CLEAR ANSWER FROM THE PATIENT ON WHETHER THEY HAD ANY STIMULATION ISSUES. THE NON-RECHARGEABLE IPG HAD TO BE REPLACED. PRE-OPERATIVELY, IT WAS NOTED THAT THE LEAD DISPLAYED HIGH IMPEDANCES ON MULTIPLE CONTACTS. THEREFORE, THE PHYSICIAN DECIDED TO EXPLANT AND REPLACE BOTH THE IPG AND LEAD. POST OPERATIVELY, THE PATIENT WAS NOTED TO HAVE RECOVERED AND RECEIVING PAIN RELIEF.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
859149 WAVEWRITER ALPHA PRIME 16 STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION CORPORATION SC-1416 214677

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention